Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Core Insights - Nuwellis, Inc. will release its financial results for Q3 2025 on November 12, 2025, and will host a conference call at 9:00 AM ET to discuss these results and provide a business update [1] Company Overview - Nuwellis, Inc. is a medical technology company focused on solutions for patients with cardio-renal conditions, particularly addressing the relationship between the heart and kidneys [1] - The company is dedicated to transforming the lives of patients suffering from fluid overload through innovation and collaboration [3] - Nuwellis is headquartered in Minneapolis and has a wholly owned subsidiary in Ireland [3] Product Information - The Aquadex SmartFlow system is designed for ultrafiltration therapy, effectively removing excess fluid from patients suffering from hypervolemia [4] - The system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kg or more, whose fluid overload is unresponsive to medical management [4] - Treatments must be administered by trained healthcare providers in clinical settings under physician prescription [4]